Medpace (MEDP) Insider Trading & Ownership $337.28 +2.13 (+0.64%) (As of 12/20/2024 05:16 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends Medpace (NASDAQ:MEDP) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage20.30%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)5Amount OfInsider Selling(Last 12 Months)$88.47 M Get MEDP Insider Trade Alerts Want to know when executives and insiders are buying or selling Medpace stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address MEDP Insider Buying and Selling by Quarter Ad Darwin2025 AI Stock Picks: 2 Hidden Gems Under $10/ShareThe AI sector continues to make waves as we move into 2025, and now is a prime opportunity to get involved—without stretching your budget! We’ve just uncovered 2 promising AI stocks trading for under $10/share, and they’re positioned for impressive growth in the coming months.👉[Click here to get your FREE report delivered instantly!] Medpace Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails7/26/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$381.47$1,001 - $15,0006/21/2024Josh GottheimerU.S. Congress Member (D-NJ)Sell$404.03$1,001 - $15,0005/28/2024August J TroendleCEOSell5,695$395.49$2,252,315.55 5/24/2024August J TroendleCEOSell3,987$395.22$1,575,742.14 5/22/2024August J TroendleCEOSell55$400.00$22,000.00 5/8/2024August J TroendleCEOSell4,782$400.58$1,915,573.56 4/29/2024August J TroendleCEOSell15,102$400.69$6,051,220.38 3/15/2024Susan E BurwigVPSell102$403.00$41,106.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 3/14/2024Ashley M KeatingDirectorSell250$409.87$102,467.50 3/8/2024August J TroendleCEOSell25,000$408.71$10,217,750.00 3/6/2024August J TroendleCEOSell100,000$412.98$41,298,000.00 2/20/2024Medpace Investors, LlcMajor ShareholderSell13,988$386.39$5,404,823.32 2/16/2024Medpace Investors, LlcMajor ShareholderSell50,000$391.75$19,587,500.00 (Data available from 1/1/2013 forward) MEDP Insider Trading Activity - Frequently Asked Questions Who is on Medpace's Insider Roster? The list of insiders at Medpace includes Ashley M Keating, August J Troendle, Kevin M Brady, Medpace Investors, Llc, Robert O Kraft, Stephen P Ewald, and Susan E Burwig. Learn more on insiders at MEDP. What percentage of Medpace stock is owned by insiders? 20.30% of Medpace stock is owned by insiders. Learn more on MEDP's insider holdings. Which Medpace insiders have been selling company stock? The following insiders have sold MEDP shares in the last 24 months: Ashley M Keating ($102,467.50), August J Troendle ($158,911,177.97), Kevin M Brady ($1,785,000.00), Medpace Investors, Llc ($85,053,605.12), Robert O Kraft ($3,661,463.94), Stephen P Ewald ($5,558,421.50), and Susan E Burwig ($3,201,528.65). How much insider selling is happening at Medpace? Insiders have sold a total of 871,051 Medpace shares in the last 24 months for a total of $258,273,664.68 sold. Which members of congress are trading Medpace? Josh Gottheimer (D-NJ) has sold shares of Medpace in the last year totaling $24,000. Medpace Key ExecutivesDr. August James Troendle M.D. (Age 68)Chairman & CEO Compensation: $1.65MMr. Jesse J. Geiger BBA (Age 50)CPA, President Compensation: $945.08kMr. Kevin M. Brady (Age 49)CFO & Treasurer Compensation: $690.48kMs. Susan E. Burwig BSN (Age 61)MA, Executive Vice President of Operations Compensation: $1.12MMr. Stephen P. Ewald J.D. (Age 55)Chief Compliance Officer, General Counsel & Corporate Secretary Compensation: $914.64kBrandon EbkenChief Information OfficerMs. Lauren MorrisAssociate Director of Investors RelationsMr. Todd MeyersVice President of Business Development & MarketingJohn T. Wynne MBASenior Vice President of Commercial Operations & Clinical Pharmacology UnitMr. Reinilde Heyrman M.D. (Age 63)Chief Medical Officer of Medical Department More Insider Trading Tools from MarketBeat Related Companies IQV Insider Transactions RDDT Insider Transactions CPAY Insider Transactions TRU Insider Transactions Z Insider Transactions TOST Insider Transactions ZG Insider Transactions GFL Insider Transactions RBA Insider Transactions ICLR Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:MEDP) was last updated on 12/21/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredVladimir Lenin was right…The Magnificent 7 could be in for a world of pain… And the insiders know it. It’s why Jeff Bezos just sold ...Porter & Company | SponsoredMusk’s new company could top a trillion?The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...Paradigm Press | SponsoredMissed Nvidia? Watch this ASAPThis little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medpace Holdings, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medpace With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MEDP Stock Alerts